Ultrastructural alterations of pulmonary surfactant in rat lungs after inhibition of protein synthesis by puromycin.
The effects of systematically administered puromycin on the fine structure of the lung were studied. The effects varied depending on the duration of exposure and the time interval between the last injection and sacrifice. After short term exposure most surfactant had separated from the epithelial surface and profound alterations in the tubular myelin structure were seen. After moderate duration of exposure a previously undescribed multilamellar lining layer was observed which was often detached from the alveolar epithelium. Six hours after the last injection the regular tubular myelin pattern reappeared. Puromycin treatment results in inhibition of various proteins synthesized by type II epithelial cells. Inhibition of synthesis of some proteins, most probably that of glycoprotein A, causes a primary effect on the structure of surfactant. The loss of at least some of the cytoskeletal proteins in Type II epithelial cells apparently results in interference with exocytosis of lamellar body contents.
Groniowski
J
J
Polish Academy of Sciences, Medical Research Centre, Warsaw.
Walski
M
M
Celary-Walska
R
R
Groniowski
M
M
D000818:Animals; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D008297:Male; D011650:Pulmonary Alveoli / Q000187:drug effects / Q000648:ultrastructure; D011663:Pulmonary Surfactants / Q000096:biosynthesis / Q000187:drug effects / Q000648:ultrastructure*; D011691:Puromycin / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D011663:Pulmonary Surfactants; D011691:Puromycin